Table 1
From: Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
BASELINE | 3 MONTHS | 6 MONTHS | INFERENCE | |
|---|---|---|---|---|
VAS (mm) | 23,08±17,02 | 29,31±18,69 | 23,50±16,33 | p = 0,670 |
HAQ | 0,69±0,59 | 0,85±0,61 | 0,76±0,69 | p = 0,001 |
DAS28 | 2,24±0,36 | 2,64±0,85 | 2,65±0,58 | p = 0,51 |